机译:22q11的抑癌基因适应症涉及室间隔膜肿瘤的发病机理,与hSNF5 / INI1不同
Department of Neurology University of Bonn Medical Center 53105 Bonn Germany;
Department of Neuropathology University of Bonn Medical Center Sigmund-Freud-Strasse 25 53105 Bonn Germany;
Departments of Pediatric Neurosurgery University of Würzburg 97080 Würzburg Germany;
Department of Neurosurgery University of Würzburg 97080 Würzburg Germany;
Department of Neurosurgery University of Würzburg 97080 Würzburg Germany;
Department of Neurosurgery University of Würzburg 97080 Würzburg Germany;
Department of Neuropathology University of Bonn Medical Center Sigmund-Freud-Strasse 25 53105 Bonn Germany;
Department of Neuropathology Humboldt University of Berlin 13353 Berlin Germany;
Department of Neuropathology University of Bonn Medical Center Sigmund-Freud-Strasse 25 53105 Bonn Germany;
hSNF5/INI1 Ependymoma Tumor suppressor gene Brain neoplasms;
机译:hSNF5 / INI1基因的畸变仅限于小儿实体瘤中的恶性横纹肌瘤或非典型类畸形/长石ha瘤。
机译:患有第二原发性脑肿瘤的肾横纹肌瘤中hSNF5 / INI1基因的突变。
机译:在横纹肌瘤中靶向细胞周期蛋白D1(INI1 | [sol] | hSNF5的下游效应子)
机译:子宫中子或γ-辐照诱导的鼠肿瘤中的癌肠和肿瘤抑制基因
机译:基于INI1作为抑癌功能的针对横纹肌瘤的靶向治疗方法的开发。
机译:候选抑癌基因IRF6通过调节PI3K调节亚基PIK3R2的表达参与人类乳腺癌的发病
机译:染色体3p上的肿瘤抑制基因参与肺癌和其他癌症的发病机制